Vestal-Point-Capital-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
63
Total Value
1400316542
Accession Number
0001974915-25-000005
Form Type
13F-HR
Manager Name
Vestal-Point-Capital-Lp
Data Enrichment
97% identified
61 identified2 unidentified

Holdings

63 positions
Manager:
Search and click to pin securities to the top
Page 2 of 4
Ascendis Pharma A/S
Shares:150.1K
Value:$23.4M
Astria Therapeutics, Inc.
Shares:4.2M
Value:$22.3M
Day One Biopharmaceuticals, Inc.
Shares:2.6M
Value:$20.6M
Dyne Therapeutics, Inc.
Shares:1.8M
Value:$18.8M
Ultragenyx Pharmaceutical Inc.
Shares:500.0K
Value:$18.1M
Liquidia Corp
Shares:1.2M
Value:$18.1M
Cogent Biosciences, Inc.
Shares:3.0M
Value:$18.0M
ESTABLISHMENT LABS HOLDINGS INC.
Shares:433.2K
Value:$17.7M
Verona Pharma plc
Shares:267.6K
Value:$17.0M
PERRIGO Co plc
Shares:587.6K
Value:$16.5M
GE HealthCare Technologies Inc.
Shares:204.1K
Value:$16.5M
B6S7WD106
Shares:2.3M
Value:$16.2M
GLOBUS MEDICAL INC
Shares:200.0K
Value:$14.6M
Nurix Therapeutics, Inc.
Shares:1.1M
Value:$13.4M
Sarepta Therapeutics, Inc.
Shares:200.0K
Value:$12.8M
BRUKER CORP
Shares:300.0K
Value:$12.5M
Cidara Therapeutics, Inc.
Shares:504.5K
Value:$10.9M
Black Diamond Therapeutics, Inc.
Shares:5.6M
Value:$8.7M
MoonLake Immunotherapeutics
Shares:200.0K
Value:$7.8M
Solid Biosciences Inc.
Shares:1.8M
Value:$6.5M